Showing 201-210 of 1536 results for "".
Winning Combinations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/winning-combinations/19740/When it comes to helping patients achieve a youthful look, it’s all about the journey, Suneel Chilukuri, MD tells host Joel L. Cohen, MD. You need to continuously update treatment recommendations as patients age and take advantage of combining neuromodulators, fillers, skincare, and energy-based devAK Treatment Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-treatment-pearls/19731/Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-Hot Topic: Picture Perfect
https://practicaldermatology.com/topics/practice-management/hot-topic-picture-perfect/19567/Standardizing before and after photos in your practice is a must, explains Todd E. Schlesinger, MD. He sits down with Joel L. Cohen, MD to offer tips on improving the quality of photos from what type of camera to use to standardizing camera settings, the angle of photos, and the backdrop used.Updates from the AAD Annual Meeting in San Diego
https://practicaldermatology.com/topics/practice-management/updates-from-the-aad-annual-meeting-in-san-diego/18332/From cosmetic interventions to therapeutic breakthroughs for common dermatoses, and new technologies for practice, the latest innovations take center stage at the 2018 Annual Meeting of the American Academy of Dermatology. Joel L. Cohen, MD; Yolanda Lenzy, MD, MPH; Junko Takeshita, MD, PhD, MSCE; anNeuromodulators in Medical Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neuromodulators-in-medical-dermatology/18520/Physicians are exploring the effects of botulinum toxins on several medical dermatology conditions. Erin Gilbert, MD talks to Joel Cohen, MD about her experience treating rosacea, and discusses the need for better randomized trials to explore treatment options.To Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.Scientifically Speaking: Sunscreen Facts from Steven Wang, MD
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-sunscreen-facts-from-steven-wang-md/19862/Which sunscreen ingredients work best? How can dermatologists get patients to apply properly? And what is the role for sun protective clothing? Host Joel L. Cohen, MD talks to Steven Wang, MD, about facts and misconceptions in the science of sun protection.New and Emerging Treatments in Aesthetic Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-and-emerging-treatments-in-aesthetic-dermatology/18819/Joel Cohen, MD provides an update on innovative treatments in aesthetic dermatology that have really blossomed in the last year, such as combination non-ablative and ablative fractional and bipolar radiofrequency. He also says there are now great modalities to treat the whole patient—from the neck,Scientifically Speaking: The Truth About Skincare
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-the-truth-about-skincare/19876/From workhorse ingredients like antioxidants and retinol to newer molecules that address pigmentation and aging, there is a lot of noise in the skincare marketplace. And that's without talking about "natural" formulations. Joel L. Cohen, MD gets to the heart of the science, in a conversation with DeSystemic Implications of Psoriasis
https://practicaldermatology.com/topics/psoriasis/systemic-implications-of-psoriasis/18636/Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfand, MD, talks about the increased risk for diabetes and cardiovascular disease in patients with psoriasis, as well as the clinician's role in educating patients about their disease